Mode
Text Size
Log in / Sign up

Telemedicine applications in general practice show positive clinical outcomes for chronic diseasesNew review shows telemedicine works well for chronic illness

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider telemedicine may improve clinical outcomes in general practice chronic disease care, but evidence is limited by short follow-up.

A structured review of 22 studies, including RCTs and observational designs, assessed telemedicine applications—primarily asynchronous—for patients with chronic somatic diseases in general practice. The review included patients with conditions such as Type 2 Diabetes, Hypertension, and Heart Failure, with 95% of studies having a follow-up of 12 months or less.

The primary outcome was not reported. For secondary outcomes, over 50% of studies found positive significant effects on clinical outcomes. Economic effects and patient experiences were also assessed, but specific effect sizes, absolute numbers, and p-values or confidence intervals were not reported.

Safety and tolerability data were not reported; adverse events, serious adverse events, and discontinuations were not specified. The review notes that the evidence reports associations from RCTs and observational studies, with no evidence that telemedicine causes worsening of outcomes.

Key limitations include a focus on diseases that are not the most common reasons for encounter, short follow-up periods, and studies that were not initiated by the specialty itself. The authors state that evidence supports telemedicine use in general practice, but certainty is not quantified. Findings should not be generalized to specialties other than general practice, and long-term benefits beyond 12 months are not established.

New review shows telemedicine works well for chronic illness.

Why remote care matters for heart health

Think of your body like a garden. You need regular checks to stop weeds from growing. Telemedicine acts like a weekly watering schedule. It keeps things steady without digging up the soil.

For people with chronic diseases, consistency is key. They do not need a full exam every week. They need someone to check their numbers and answer questions. This remote support can prevent small problems from becoming big ones.

The new review looked at twenty-two key studies. They covered the years from 2011 to 2025. The focus was on general practice and chronic diseases.

What the data says about long-term safety

More than half of these reports showed positive results. Patients with diabetes and heart failure did well. There was no sign of harm from the visits.

Most studies used asynchronous applications. This means patients sent messages or data instead of live video. The doctor reviewed the information later and replied. This method saves time for everyone involved.

This does not mean every doctor offers video visits today.

The research found that eighty percent of these studies used this method. Ninety-five percent of the studies observed a time period of twelve months or less. This is important for understanding the full picture.

Why follow-up time matters for your care

The findings demonstrate that there is evidence supporting the use of telemedicine. However, the majority of the studies focused on diseases that are not among the most common reasons for encounter.

The studies had a rather short follow-up observation period. We do not know what happens after that time passes. Long-term effects might look different than short-term results.

The fact that the studies were not initiated by the specialty itself is the most likely explanation for these findings. Independent researchers often look at data that doctors might overlook. This adds a layer of trust to the results.

What happens next for virtual health visits

Experts say this supports using technology for routine checks. It fills gaps when travel is hard or time is tight. You should talk to your provider about options.

Ask if a video call fits your needs. It might save you a trip to the office. Science moves slowly to ensure safety first.

The research had limits. Many studies were not started by doctors. Some focused on less common reasons for visits. More work is needed to see long-term effects.

Approval processes will take time to update guidelines. But the path forward looks clearer than before. Trust in these tools is growing with every new report.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
IntroductionTelemedicine (TM) in general practice has declined following the pandemic. One reason is deemed to be the lack of clear evidence regarding the quality of care provided by TM. Therefore, the aim of this review, was to systematically present the existing evidence concerning the use of TM applications in general practice.MethodsThis structured review includes randomized controlled trials (RCT) and observational studies with a control group. The literature search targeted the time period from 2011 to 2025, screened by two researchers who focused in particular on medical efficacy, economic effects, and patient experiences.ResultsThe searches in the PubMed and Cochrane databases yielded 488 publications (30 June 2025). After filtering out duplicates and performing multi-step screening (title, abstract and full text), 22 studies were included in the final analysis. Over 50% of these studies found positive significant effects in the clinical outcomes. Over 80% of the included studies entailed asynchronous applications and 95% of the studies observed a time period of 12 months or less. The studies focused primarily on chronic somatic diseases, including diabetes mellitus type 2, hypertension and heart failure.DiscussionOur findings demonstrate that there is evidence supporting the use of telemedicine in general practice. However, the majority of the studies focused on diseases that are not among the most common reasons for encounter and had a rather short follow-up observation period. The fact that the studies were not initiated by the specialty itself is the most likely explanation for these findings. There was no evidence that TM causes (significant) worsening of outcomes in the conditions addressed in the included studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.